TY - JOUR
T1 - Dissecting the Role of Single Regions of an IAPP Mimic and IAPP in Inhibition of Aβ40 Amyloid Formation and Cytotoxicity
AU - Andreetto, Erika
AU - Yan, Li Mei
AU - Caporale, Andrea
AU - Kapurniotu, Aphrodite
PY - 2011/6/14
Y1 - 2011/6/14
N2 - Alzheimer's disease (AD) and type 2 diabetes (T2D) are linked to the self-association of β-amyloid peptide (Aβ) and islet amyloid polypeptide (IAPP), respectively. We have shown that IAPP-GI, a soluble IAPP analogue and mimic of nonamyloidogenic and nontoxic IAPP, binds Aβ with high affinity and blocks its cytotoxic self-assembly and fibrillogenesis. We have also shown that IAPP and Aβ interact with each other into nonfibrillar and nontoxic heterocomplexes that suppress cytotoxic self-association by both polypeptides. The Aβ-IAPP interaction might thus be a molecular link between AD and T2D. We studied the role of individual IAPP-GI and IAPP regions in their inhibitory function on Aβ40 self-association and cytotoxicity. We found that the presence of the two hot-spot regions of the Aβ-IAPP interaction interface in IAPP(8-28) is not sufficient for inhibitory function and that, in addition to IAPP(8-28), the presence of the N-terminal region IAPP(1-7) is absolutely required. By contrast, the C-terminal region, IAPP(30-37), is not required although its presence together with IAPP(1-7) in IAPP-GI results in a marked enhancement of the inhibitory effect as compared to IAPP(1-28)-GI. We suggest that the inhibitory effect of IAPP-GI and IAPP on Aβ40 fibrillogenesis and cell toxicity is mediated primarily by interactions involving the hot regions of the Aβ-IAPP interaction interface and the N terminus of IAPP while a concerted and likely structure-stabilizing action of the N- and C-terminal IAPP regions potentiates this effect. These results identify important molecular determinants of the amyloid suppressing function of the Aβ40-IAPP interaction and could contribute to the design of novel inhibitors of Aβ40 aggregation and cell degeneration. Block buster: We have previously found that the interaction of the type 2 diabetes islet amyloid polypeptide (IAPP) and its nonamyloidogenic mimic IAPP-GI with the Alzheimer's disease β-amyloid peptide (Aβ) blocks Aβ aggregation and cytotoxicity. Here we uncover the role of individual IAPP-GI and IAPP regions in the inhibitory function on Aβ40 amyloidogenesis and cytotoxicity and suggest a molecular basis for this effect.
AB - Alzheimer's disease (AD) and type 2 diabetes (T2D) are linked to the self-association of β-amyloid peptide (Aβ) and islet amyloid polypeptide (IAPP), respectively. We have shown that IAPP-GI, a soluble IAPP analogue and mimic of nonamyloidogenic and nontoxic IAPP, binds Aβ with high affinity and blocks its cytotoxic self-assembly and fibrillogenesis. We have also shown that IAPP and Aβ interact with each other into nonfibrillar and nontoxic heterocomplexes that suppress cytotoxic self-association by both polypeptides. The Aβ-IAPP interaction might thus be a molecular link between AD and T2D. We studied the role of individual IAPP-GI and IAPP regions in their inhibitory function on Aβ40 self-association and cytotoxicity. We found that the presence of the two hot-spot regions of the Aβ-IAPP interaction interface in IAPP(8-28) is not sufficient for inhibitory function and that, in addition to IAPP(8-28), the presence of the N-terminal region IAPP(1-7) is absolutely required. By contrast, the C-terminal region, IAPP(30-37), is not required although its presence together with IAPP(1-7) in IAPP-GI results in a marked enhancement of the inhibitory effect as compared to IAPP(1-28)-GI. We suggest that the inhibitory effect of IAPP-GI and IAPP on Aβ40 fibrillogenesis and cell toxicity is mediated primarily by interactions involving the hot regions of the Aβ-IAPP interaction interface and the N terminus of IAPP while a concerted and likely structure-stabilizing action of the N- and C-terminal IAPP regions potentiates this effect. These results identify important molecular determinants of the amyloid suppressing function of the Aβ40-IAPP interaction and could contribute to the design of novel inhibitors of Aβ40 aggregation and cell degeneration. Block buster: We have previously found that the interaction of the type 2 diabetes islet amyloid polypeptide (IAPP) and its nonamyloidogenic mimic IAPP-GI with the Alzheimer's disease β-amyloid peptide (Aβ) blocks Aβ aggregation and cytotoxicity. Here we uncover the role of individual IAPP-GI and IAPP regions in the inhibitory function on Aβ40 amyloidogenesis and cytotoxicity and suggest a molecular basis for this effect.
KW - Alzheimer's disease
KW - Amyloid beta-peptides
KW - Inhibitors
KW - Islet amyloid polypeptide
KW - Protein-protein interactions
UR - http://www.scopus.com/inward/record.url?scp=79958694883&partnerID=8YFLogxK
U2 - 10.1002/cbic.201100192
DO - 10.1002/cbic.201100192
M3 - Article
C2 - 21630409
AN - SCOPUS:79958694883
SN - 1439-4227
VL - 12
SP - 1313
EP - 1322
JO - ChemBioChem
JF - ChemBioChem
IS - 9
ER -